QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
NASDAQ:CELC

Celcuity - CELC Stock Forecast, Price & News

$10.05
-0.36 (-3.46%)
(As of 08/16/2022 12:00 AM ET)
Add
Compare
Today's Range
$9.65
$10.44
50-Day Range
$7.17
$10.64
52-Week Range
$4.81
$23.11
Volume
30,404 shs
Average Volume
67,667 shs
Market Capitalization
$150.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$34.00

Celcuity MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
238.3% Upside
$34.00 Price Target
Short Interest
Healthy
2.72% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.28mentions of Celcuity in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$8,934 Sold Last Quarter
Proj. Earnings Growth
Decreasing
From ($1.29) to ($1.57) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.26 out of 5 stars

Medical Sector

465th out of 1,124 stocks

Medical Laboratories Industry

14th out of 28 stocks

CELC stock logo

About Celcuity (NASDAQ:CELC) Stock

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Analyst Upgrades and Downgrades

Separately, Craig Hallum dropped their price target on Celcuity from $30.00 to $20.00 and set a "na" rating for the company in a research note on Tuesday, May 17th.

Celcuity Price Performance

Shares of Celcuity stock opened at $10.41 on Tuesday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 22.37 and a current ratio of 22.37. The stock's fifty day moving average is $9.14 and its 200 day moving average is $8.62. The stock has a market cap of $155.54 million, a P/E ratio of -5.05 and a beta of 1.22. Celcuity has a one year low of $4.81 and a one year high of $23.11.

Celcuity (NASDAQ:CELC - Get Rating) last posted its quarterly earnings results on Monday, May 16th. The company reported ($0.53) earnings per share for the quarter, missing the consensus estimate of ($0.51) by ($0.02). Sell-side analysts anticipate that Celcuity will post -1.29 earnings per share for the current year.

Receive CELC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Celcuity and its competitors with MarketBeat's FREE daily newsletter.

CELC Stock News Headlines

Celcuity: Q2 Earnings Insights - Benzinga
Celcuity (CELC) Scheduled to Post Earnings on Thursday
See More Headlines
Receive CELC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Celcuity and its competitors with MarketBeat's FREE daily newsletter.

CELC Company Calendar

Last Earnings
11/07/2021
Today
8/16/2022
Next Earnings (Estimated)
11/14/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CELC
Fax
N/A
Employees
39
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$34.00
High Stock Price Forecast
$48.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+238.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-29,600,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$4.61 per share

Miscellaneous

Free Float
10,025,000
Market Cap
$150.16 million
Optionable
Not Optionable
Beta
1.22

Key Executives

  • Mr. Brian F. Sullivan (Age 60)
    Co-Founder, Chairman & CEO
    Comp: $259.62k
  • Dr. Lance G. Laing Ph.D. (Age 60)
    Co-Founder, Chief Science Officer, VP, Sec. & Director
    Comp: $447.92k
  • Ms. Vicky Hahne (Age 56)
    Chief Financial Officer
    Comp: $234.52k
  • Mr. Eric Lindquist
    Chief Bus. Officer
  • Dr. John R. MacDonald Dabt (Age 67)
    Ph., Ph.D., Sr. VP of R&D
  • Ms. Sheri Smith
    Acting Head of Clinical Operations
  • Mr. Igor Gorbatchevsky M.D.
    Chief Medical Officer













CELC Stock - Frequently Asked Questions

Should I buy or sell Celcuity stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Celcuity in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CELC shares.
View CELC analyst ratings
or view top-rated stocks.

What is Celcuity's stock price forecast for 2022?

1 brokers have issued 1 year target prices for Celcuity's stock. Their CELC share price forecasts range from $20.00 to $48.00. On average, they expect the company's stock price to reach $34.00 in the next twelve months. This suggests a possible upside of 238.3% from the stock's current price.
View analysts price targets for CELC
or view top-rated stocks among Wall Street analysts.

How have CELC shares performed in 2022?

Celcuity's stock was trading at $13.19 at the beginning of 2022. Since then, CELC shares have decreased by 23.8% and is now trading at $10.05.
View the best growth stocks for 2022 here
.

When is Celcuity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 14th 2022.
View our CELC earnings forecast
.

How were Celcuity's earnings last quarter?

Celcuity Inc. (NASDAQ:CELC) released its quarterly earnings results on Sunday, November, 7th. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.31) by $0.10. During the same quarter in the prior year, the firm earned ($0.24) earnings per share.

What other stocks do shareholders of Celcuity own?
When did Celcuity IPO?

(CELC) raised $18 million in an initial public offering on Wednesday, September 20th 2017. The company issued 2,000,000 shares at $8.00-$10.00 per share. Craig-Hallum Capital Group served as the underwriter for the IPO.

What is Celcuity's stock symbol?

Celcuity trades on the NASDAQ under the ticker symbol "CELC."

Who are Celcuity's major shareholders?

Celcuity's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Millennium Management LLC (3.41%), Gagnon Securities LLC (2.07%), Gagnon Advisors LLC (1.21%), Renaissance Technologies LLC (0.57%), Northern Trust Corp (0.27%) and State Street Corp (0.21%).
View institutional ownership trends
.

How do I buy shares of Celcuity?

Shares of CELC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Celcuity's stock price today?

One share of CELC stock can currently be purchased for approximately $10.05.

How much money does Celcuity make?

Celcuity (NASDAQ:CELC) has a market capitalization of $150.16 million. The company earns $-29,600,000.00 in net income (profit) each year or ($2.06) on an earnings per share basis.

How can I contact Celcuity?

Celcuity's mailing address is 16305 36TH AVENUE NORTH SUITE 100, MINNEAPOLIS MN, 55446. The official website for the company is www.celcuity.com. The company can be reached via phone at (763) 392-0767.

This page (NASDAQ:CELC) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.